MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 69 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,476,984 | -31.1% | 7,747,891 | -26.9% | 0.11% | -28.9% |
| Q4 2022 | $7,954,142 | -12.9% | 10,605,522 | 0.0% | 0.15% | -10.6% |
| Q3 2022 | $9,132,000 | -16.0% | 10,605,522 | +9.2% | 0.17% | -13.7% |
| Q2 2022 | $10,877,000 | -43.7% | 9,711,422 | -43.8% | 0.20% | -37.1% |
| Q1 2022 | $19,336,000 | -30.0% | 17,264,764 | 0.0% | 0.31% | -11.8% |
| Q4 2021 | $27,624,000 | -33.9% | 17,264,764 | 0.0% | 0.36% | -22.7% |
| Q3 2021 | $41,781,000 | -23.7% | 17,264,764 | 0.0% | 0.46% | -17.1% |
| Q2 2021 | $54,730,000 | -5.9% | 17,264,764 | +0.0% | 0.55% | +1.8% |
| Q1 2021 | $58,183,000 | +17.6% | 17,264,763 | +25.0% | 0.54% | +25.6% |
| Q4 2020 | $49,463,000 | – | 13,816,488 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |